Antiviral nucleoside analogs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8440813
APP PUB NO 20100015094A1
SERIAL NO

12522892

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compounds of Formula (I), as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of Formula (I) are useful as anti-viral agents and/or as anti-cancer agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOCRYST PHARMACEUTICALS INC4505 EMPEROR BLVD SUITE 200 DURHAM NC 27703

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Babu, Yarlagadda S Birmingham, US 104 1143
Chand, Pooran Birmingham, US 57 987
Kotian, Pravin L Birmingham, US 69 548
Kumar, V Satish Birmingham, US 41 502
Wu, Minwan Birmingham, US 43 545

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 14, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00